Increasing Skeletal Muscle Mass in Mice by Non-Invasive Intramuscular Delivery of Myostatin Inhibitory Peptide by Iontophoresis

Increasing Skeletal Muscle Mass in Mice by Non-Invasive Intramuscular Delivery of Myostatin Inhibitory Peptide by Iontophoresis

Sarcopenia is a major public health issue that affects older adults. Myostatin inhibitory-D-peptide-35 (MID-35) can increase skeletal muscle and is a candidate therapeutic agent, but a non-invasive and accessible technology for the intramuscular delivery of MID-35 is required. Recently, we succeeded...

Full description

Bibliographic Details
Main Authors: Kohki Michiue, Kentaro Takayama, Atsuhiko Taniguchi, Yoshio Hayashi, Kentaro Kogure
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceuticals
Subjects:
sarcopenia
myostatin inhibitory peptides
iontophoresis
intramuscular deliver
peptide delivery
weak electricity
Online Access:https://www.mdpi.com/1424-8247/16/3/397

Similar Items

Similar Items